Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

Gout PRPS-related

PRPS1 superactivity is an x-linked recessive disorder caused by mutations of the PRPS1 gene and characterized by uric acid overproduction. Conclusively gout devlops in these patients. Neurological symptoms are not typical of the mild form.

Systematic

Disorders of urate metabolism
Gout PRPS-related
PRPS1
Hyperuricemia
Hypouricemia
Phosphoribosylpyrophosphate synthetase superactivity

References:

1.

Zoref E et al. (1975) Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts.

external link
2.

Becker MA et al. (1996) Overexpression of the normal phosphoribosylpyrophosphate synthetase 1 isoform underlies catalytic superactivity of human phosphoribosylpyrophosphate synthetase.

external link
3.

Takeuchi F et al. (1981) The mode of genetic transmission of gouty family with increased phosphoribosylpyrophosphate synthetase activity.

external link
4.

Simmonds HA et al. (1982) An X-linked syndrome characterised by hyperuricaemia, deafness, and neurodevelopmental abnormalities.

external link
5.

Nyhan WL et al. (1969) A new disorder of purine metabolism with behavioral manifestations.

external link
6.

Rosenberg AL et al. (1970) Hyperuricemia and neurologic deficits. A family study.

external link
7.

Becker MA et al. (1973) Gout with purine overproduction due to increased phosphoribosylpyrophosphate synthetase activity.

external link
8.

de Vries A et al. (1973) Familial gouty malignant uric acid lithiasis due to mutant phosphoribosylpyrophosphate synthetase.

external link
9.

Sperling O et al. (1973) Human erythrocyte phosphoribosylpyrophosphate synthetase mutationally altered in regulatory properties.

external link
10.

Becker MA et al. (1973) Purine overproduction in man associated with increased phosphoribosylpyrophosphate synthetase activity.

external link
11.

Sperling O et al. (1972) Accelerated erythrocyte 5-phosphoribosyl-1-pyrophosphate synthesis. A familial abnormality associated with excessive uric acid production and gout.

external link
12.

Becker MA et al. (1973) Human phosphoribosylpyrophosphate synthetase: increased enzyme specific activity in a family with gout and excessive purine synthesis.

external link
13.

Becker MA et al. (1986) Phosphoribosylpyrophosphate synthetase superactivity. A study of five patients with catalytic defects in the enzyme.

external link
14.

Becker MA et al. (1988) Inherited superactivity of phosphoribosylpyrophosphate synthetase: association of uric acid overproduction and sensorineural deafness.

external link
15.

Christen HJ et al. (1992) Distinct neurological syndrome in two brothers with hyperuricaemia.

external link
16.

Yen RC et al. (1978) Evidence for X-linkage of human phosphoribosylpyrophosphate synthetase.

external link
17.

Zoref E et al. (1977) Evidence for X-linkage of phosphoribosylpyrophosphate synthetase in man. Studies with cultured fibroblasts from a gouty family with mutant feedback-resistant enzyme.

external link
18.

Zoref E et al. (1976) Metabolic cooperation between human fibroblasts with normal and with mutant superactive phosphoribosylpyrophosphate synthetase.

external link
19.

Roessler BJ et al. (1993) Human X-linked phosphoribosylpyrophosphate synthetase superactivity is associated with distinct point mutations in the PRPS1 gene.

external link
20.

Becker MA et al. (1995) The genetic and functional basis of purine nucleotide feedback-resistant phosphoribosylpyrophosphate synthetase superactivity.

external link
21.

Becker MA et al. (1980) Variant human phosphoribosylpyrophosphate synthetase altered in regulatory and catalytic functions.

external link
22.

Becker MA et al. (1986) Superactivity of human phosphoribosyl pyrophosphate synthetase due to altered regulation by nucleotide inhibitors and inorganic phosphate.

external link
23.

Moran R et al. (2012) Phosphoribosylpyrophosphate synthetase superactivity and recurrent infections is caused by a p.Val142Leu mutation in PRS-I.

external link
24.

Orphanet article

Orphanet ID 411536 external link
25.

OMIM.ORG article

Omim 300661 external link
Update: Aug. 14, 2020
Copyright © 2005-2024 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues | Website Credits